Foreign proceeding (ancillary)
Seventh Report dated March 8, 2024.pdf
Court officer report · 8 March 2024
A plain-language read of this filing opens with a subscription.
What we verified from this filing1 verified
- fee scheduleengagements: form: level_summary · rows: fees: 11465 · quote: Liquidator's Fees & expenses | 11,465 · row kind: bucket · rate kind: standard · name as stated: Liquidator's Fees & expenses; fees: 9315 · quote: Legal Fees and expenses | 9,315 · row kind: bucket · rate kind: standard · name as stated: Legal Fees and expenses · money: total: quote: Total | 20,780 · amount: 20780 · includes disbursements: true · approximate: false · period: end: 2023-12-31 · kind: cumulative · label: Time incurred from JPLs' appointment on 22 September 2022 to end of Q4 2023 · quote: Time incurred from JPLs' appointment on 22 September 2022 to end of Q4 2023. · start: 2022-09-22 · approval: quote: Approval of the above Liquidator's Fees and expenses will be sought in an upcoming meeting of contributories · state: sought · averages: · currency: code: USD · quote: US$'000 · invoices: · context quote: Global Cord Blood Corporation (In Provisional Liquidation) (the Company) Cause No. FSD 108 of 2022 (IKJ) · firm unverified: true · comparability quote: The above reflects market standard rates and is in alignment with the Insolvency Practitioner Rules.; form: level_summary · rows: rate: 930 · quote: Liquidator | 930 | 930 · title: Liquidator · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Liquidator; rate: 930 · quote: Liquidator | 930 | 930 · title: Liquidator · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Liquidator; rate: 785 · quote: Director | 785 | 795 · title: Director · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Director; rate: 795 · quote: Director | 785 | 795 · title: Director · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Director; rate: 670 · quote: Senior Manager | 670 | 680 · title: Senior Manager · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Senior Manager; rate: 680 · quote: Senior Manager | 670 | 680 · title: Senior Manager · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Senior Manager; rate: 560 · quote: Manager | 560 | 570 · title: Manager · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Manager; rate: 570 · quote: Manager | 560 | 570 · title: Manager · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Manager; rate: 495 · quote: Assistant Manager | 495 | 555 · title: Assistant Manager · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Assistant Manager; rate: 555 · quote: Assistant Manager | 495 | 555 · title: Assistant Manager · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Assistant Manager; rate: 390 · quote: Senior | 390 | 410 · title: Senior · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Senior; rate: 410 · quote: Senior | 390 | 410 · title: Senior · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Senior; rate: 230 · quote: Administration | 230 | 240 · title: Administration · row kind: level · rate kind: standard · rate label: Previous Rate · name as stated: Administration; rate: 240 · quote: Administration | 230 | 240 · title: Administration · row kind: level · rate kind: standard · rate label: 2024 Rate · name as stated: Administration · money: approximate: false · period: kind: unstated · approval: quote: The JPLs will seek approval of the above rate increase from the Cayman Court at the next possible opportunity. · state: sought · averages: · currency: · invoices: · context quote: Global Cord Blood Corporation (In Provisional Liquidation) (the Company) Cause No. FSD 108 of 2022 (IKJ) · firm unverified: true · comparability quote: The above reflects market standard rates and is in alignment with the Insolvency Practitioner Rules.